Sentinel lymph node and neoadjuvant therapy in breast cancer;Ganglio centinela y neoadyuvancia en cáncer de mama

Revista Espanola de Medicina Nuclear

Volumn 29, Issue 6, 2010, Pages 319-320

  Munoz M ^a   Pahisa, J ^a   Xavier Caparros F ^a   Vidal Sicart, S ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; ECHOMAMMOGRAPHY; HUMAN; LYMPHADENECTOMY; MASTECTOMY; NOTE; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; ARTIFACTS; BREAST NEOPLASMS; CASE MANAGEMENT; CLINICAL TRIALS AS TOPIC; FEMALE; FIBROSIS; HUMANS; INFORMED CONSENT; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 78049509560     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/j.remn.2010.10.003     Document Type: Note

References (10)

1. Solá M, Fraile M. Ganglio centinela y neoadyuvancia en cáncer de mama: en busca del mejor escenario. Rev Esp Med Nucl. S0212-6982(10)00169-2.
2. Grube B.J., Christy C.J., Black D., Martel M., Harris L., Weidhaas J., et al. Breast sentinel lymph node dissection before preoperative chemotherapy. Arch Surg 2008, 143:692-699.
3. Schrenk P., Tausch C., Wölfl S., Bogner S., Fridrik M., Wayand W. Sentinel node mapping performed before preoperative chemotherapy may avoid axillary dissection in breast cancer patients with negative or micrometastatic sentinel nodes. Am J Surg 2008, 196:176-183.
4. Shen J., Gilcrease M.Z., Babiera G.V., Ross M.I., Meric-Bernstam F., Feig B.W., et al. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 2007, 109:1255-1263.
5. Van Rijk M.C., Nieweg O.E., Rutgers E.J., Oldenburg H.S., Olmos R.V., Hoefnagel C.A., et al. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection. Ann Surg Oncol 2006, 13:475-479.
6. Ollila D.W., Neuman H.B., Sartor C., Carey L.A., Klauber-Demore N. Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancers. Am J Surg 2005, 190:371-375.
7. Cox C.E., Cox J.M., White L.B., Stowell N.G., Clark J.D., Allred N., et al. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer. Ann Surg Oncol 2006, 13:483-490.
8. Khan A., Sabel M.S., Nees A., Diehl K.M., Cimmino V.M., Kleer C.G., et al. Comprehensive Axillary Evaluation in Neoadjuvant Chemotherapy Patients With Ultrasonography and Sentinel Lymph Node Biopsy. Ann Surg Oncol 2005, 12:697-704.
9. Mamounas E.P., Brown A., Anderson S., Smith R., Julian T., Miller B., et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol B-27. J Clin Oncol 2005, 23:2694-2702.
10. Xing Y., Foy M., Cox D.D., Kuerer H.M., Hunt K.K., Cornier J.N. Meta-analysis of sentinel lymph-node biopsy after preoperative chemotherapy in patients with breast cancer. Brit J Surg 2006, 93:539-546.